AZV logo

16. 7. 2019

AZV ČR logo

At the end of June, the public tender of the Ministry of Health for the support of applied medical research (AZV projects) was closed. Last year, twenty-seven projects were submitted, of which six were successful. This year, the researchers of the St. Anne's University Hospital were handed over total of 36 applications, including 16 under the International Clinical Research Center. The total amount of funds required exceeds four hundred million crowns. This would be able to support research not only in the fields of cancer, cardiovascular problems or Alzheimer's disease and other diseases from next year, but also new methods of using biomaterials, systems based on machine learning or genome sequencing.

The results of the tender will be published on 21 February 2020.

Nanopeptidy a nanosacharidy ilustrační náhled

8. 7. 2019

The CSM team (Cardiovascular System - Mechanobiology) will receive more than five million crowns for nanopeptides and nanosaccharides research. As one of the partners, he joined the PEPSA-MATE project (Nanopeptides and Nanosaccharides for Advanced and Sustainable Materials). The coordinator is University of Rome Tor Vergata and other institutions from Germany, Italy, Spain, Australia and Cuba are involved as a partners.

The objective of PEPSA-MATE is to turn biopolymers into sustainable products using innovative technologies. The result will be an alternative biomaterial to conventional, non-degradable synthetic polymers and inorganic materials. Three areas of research will be explored; firstly, phytoglycogenic nanoparticles to fabricate of bioadhesives, bioplastics and drug carriers, as well as ultrasonic fabrication of biofunctional nanopeptides as well as nanostructured saccharide microparticles as a universal platform to deliver of a wide range of therapeutic molecules. PEPSA-MATE includes interdisciplinary research on nanomaterials, polysaccharides and peptides, cell biology, biophysics, and computational modeling.

In terms of international impact, PEPSA-MATE will allow long-term collaboration between research teams not only in European countries (Italy, Czech Republic, Germany and Spain), but also in four non-EU countries (Australia, Brazil, Cuba and South Africa).

The grant is planned for 2019-2022.

Nanopeptids and nanosacharides thumb
Gorazd Stokin - Director of FNUSA-ICRC

5. 7. 2019

Gorazd Stokin - Chief of FNUSA-ICRC

Dear colleagues,

This week there were several press releases regarding International Clinical Research Centre (FNUSA-ICRC) of St. Anne’s University Hospital (FNUSA). FNUSA-ICRC has not been involved and it also does not have competencies to be involved in the matters reported by the press.

In recent years, we have worked hard together to build good relationships and gain a good reputation. We work in many areas and our common goal is satisfaction of patients. I do not want this mutual trust to be damaged by some articles.

On a separate note, I visited Minister of Health on May 28 to update him on recent successes of FNUSA-ICRC and to emphasise the need for a clear financial strategy beyond 2021 as mentioned to you in advance during the FNUSA-ICRC May 16 business meeting.

I personally do not know the rationale behind the press releases, which likely attempt to erode relationship between FNUSA-ICRC and the rest of FNUSA. Please rest assured that FNUSA-ICRC will continue working hard as a proud member of the FNUSA community.

FNUSA Director M.Pavlik and I have followed up and discussed the press release situtation carefully and stay united in our view and response.

I believe that these articles have not harmed the cooperation between FNUSA and FNUSA-ICRC part in the future and that we will continue to work together to help developing  patient's  care.

Yours sincerely,

Gorazd B. Stokin, MD, PhD, FAAN
Chair - International Clinical Research Centre

Philips Director for Central and Eastern Europe - FNUSA-ICRC thumb

27. 6. 2019

At the end of June, Philips' Central and Eastern European CEO Reinier Schlatmann and several colleagues from the company's regional headquarters and the Prague office for the Czech Republic visited our center. Our center uses Philips technology in the areas of sleep medicine, magnetic resonance imaging for cardiology, heart failure, and circulatory diseases. The main topic of the visit was cooperation on the development of new technologies of the company. For several years our center has been involved in testing new technologies of the company in the field of sleep medicine.

Philips' Central and Eastern European CEO Reinier Schlatmann at FNUSA-ICRC
Prof. Ondrej Ludka FNUSA-ICRC

24. 6. 2019

Prof. Ondrej Ludka - SMED team at FNUSA-ICRC

Appointment letters to new professors were awarded by the Minister of Education, Youth and Sports Robert Plaga last week. The appointees received the highest academic degree in the Karolinum Large Assembly Hall, Prague. One of them was Ondřej Ludka, the Head of our Sleep Medicine research team, in the field of internal medicine.

Prof. Ludka's research focuses on the importance of risk factors, such as breathing disorders during sleep or its disruption - the so-called sleep apnea, and their association with obesity and other cardiovascular diseases including myocardial infarction. He is the leader of our Cardiovascular Sleep Center - one of the few institutions specializing in the diagnosis and treatment of sleep disorders in the EU in patients with cardiovascular disease. Prof. Ludka represents the Czech Republic in European sleep associations and participates in their activities. For example, since 2017, our center has been part of the European Sleep Apnea Database (ESADA). We have provided data on more than 700 patients and are now among two institutions with the highest number of patients included in the project each year. Thanks to Prof. Ludka's effort, we are going to host the ESADA European Sleep Research Society project meeting in January 2020. Therefore, for a few days, Brno will host experts from different parts of Europe whose research contributes to healthier sleep, which in turn decreases the risk of further health complications.

FNUSA-ICRC Grant competition

20. 6. 2019

During April, an internal grant competition was launched to support emerging scientific projects: "Translating Research to Impact the Quality of Life". The deadline for submission of proposals was at the end of May and is currently being evaluated by independent experts from ISAB Board FNUSA-ICRC.

In total, thirteen proposals were submitted, which were divided into four evaluation panels. The first panel evaluates the proposals submitted by researchers from St. Anne´s University Hospital Brno, others are focused on proposals of researchers from FNUSA-ICRC in the section Clinical Research, Molecular Genetics and Disease Modelling. "The aim of this competition was to motivate researchers not to be afraid to submit grant applications," said Eliška Skalická, FNUSA-ICRC grant specialist, adding: "We will see in the future whether this plan was successful, but it is a very good start."

The results of the internal grant competition will be announced during July.

FNUSA-ICRC grant competition
Go to top